The U.S. Global Health Budget: Analysis of Appropriations for Fiscal Year 2015
This budget analysis reviews U.S. funding for global health programs in the FY15 Omnibus Appropriations bill, signed into law by the President on December 16, 2014.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This budget analysis reviews U.S. funding for global health programs in the FY15 Omnibus Appropriations bill, signed into law by the President on December 16, 2014.
The FY15 Omnibus Appropriations Act contains $5.4 billion in emergency funding to address the Ebola crisis – a significant increase in total U.S. support for global health. Aside from the additional funding for Ebola, global health funding remained essentially flat at $9.2 billion, according to a new Kaiser Family Foundation funding analysis.
At 10:30 a.m. ET on June 23, the Kaiser Family Foundation will host a town hall forum with Ambassador Deborah L.
This issue brief provides an overview of the Biden administration’s COVID-19 and global health actions to date, as well as likely ones on the horizon, and identifies key policy issues and outstanding questions ahead.
A new KFF analysis finds that across 46 PEPFAR countries and among six different indicators of progress, the majority (40) has met at least one target. The analysis is part of a dashboard that provides a detailed look at progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates.
This year, Congress will consider reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR). This Policy Watch provides fast facts about the program and top issues related to its authorization and funding.
The news today about the efficacy of a new long-acting injectable PrEP, the second such breakthrough announcement in recent months, is nothing short of groundbreaking.
This analysis assesses the association between PEPFAR investments and several economic and educational outcomes. It finds that the program was associated with a significant increase in the GDP growth rate per capita and a decrease in the share of girls and boys of primary school age who were not in school.
Includes all of PEPFAR’s multi-year strategies, as well as related documents.
This timeline provides a detailed overview of actions, including counter-actions, related to the administration’s efforts to freeze all U.S. foreign aid and dissolve the U.S. Agency for International Development (USAID).
© 2025 KFF